Najat Khan

Director & CEO and President

Director & CEO and President at RECURSION PHARMACEUTICALS, INC., filing insider transactions on 2026-09-08.

Total Purchases

—

0 transactions

Total Sales

$79K

1 transaction

Companies Traded

1 total filings

Active Since

2026-09-08

Last: 2026-09-08

Companies

RECURSION PHARMACEUTICALS, INC.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-08	RXRX	Sale	22.4K	$3.52	$79K	2.07M	SEC ↗